FDx Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-37,014
Closed -$727K 754
2022
Q2
$727K Sell
37,014
-10,879
-23% -$257K 0.03% 382
2022
Q1
$1.25M Buy
47,893
+502
+1% +$13.4K 0.04% 284
2021
Q4
$1.34M Sell
47,391
-2,393
-5% -$74.4K 0.04% 298
2021
Q3
$1.59M Buy
49,784
+3,808
+8% +$128K 0.05% 251
2021
Q2
$1.59M Buy
45,976
+2,458
+6% +$81.1K 0.05% 238
2021
Q1
$1.28M Buy
43,518
+9,789
+29% +$301K 0.05% 243
2020
Q4
$1.03M Buy
33,729
+9,088
+37% +$277K 0.04% 260
2020
Q3
$688K Sell
24,641
-4,578
-16% -$116K 0.03% 304
2020
Q2
$627K Buy
+29,219
New +$645K 0.03% 298

Other funds holding ELAN

FDx Advisors's ELAN Position: Q3 2022 in Review

FDx Advisors sold out of Elanco Animal Health (ELAN) in Q3 2022, closing a stake of 37,014 shares — an estimated $727K sold.

FDx Advisors first reported a position in ELAN in Q2 2020 and held it in 9 quarters. The position peaked at $1.59M in Q2 2021. 419 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

  • FDx Advisors reported no remaining Elanco Animal Health position as of Q3 2022 after selling out during the quarter.
  • FDx Advisors sold 37,014 Elanco Animal Health shares in Q3 2022, an estimated $727K.
  • FDx Advisors first reported a position in Elanco Animal Health in Q2 2020 and held it in 9 quarters.
  • FDx Advisors's Elanco Animal Health position peaked at $1.59M in Q2 2021.
  • 419 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on FDx Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.